Dr. Jonathan H. Sherman is a board-certified neurosurgeon focusing on the treatment of brain and spinal tumors. He serves as the Chief of Neurosurgical Oncology at Rutgers Cancer Institute of New Jersey. He also serves as Professor in the Department of Neurosurgery at Rutgers Robert Wood Johnson Medical School.
Dr. Sherman obtained his medical degree from the Medical College of Georgia and completed his neurosurgery residency at the University of Virginia. He then completed a fellowship at Memorial Sloan-Kettering Cancer Center in neurosurgical oncology.
A list of current clinical trials include:
A list of current publications include:
Medical Education
Medical College of Georgia
Neurosurgery Training
University of Virginia
Neurosurgical Oncology Fellowship
Memorial Sloan-Kettering Cancer Center
Awards
Washingtonian Top Doc – Past 5 years
GWU Hospital Recognition for Patient Satisfaction
CNS Vanguard Leadership Institute Cohort
PloS One Editorial Board – Long Service Award
Society Membership
Congress of Neurological Surgeons (CNS)
CNS Education Committee
CNS NEXUS Committee
American Association of Neurological Surgeons (AANS)
AANS History Section - Chair
AANS/CNS TUMOR SECTION
Executive Committee
Society of Neuro-Oncology (SNO)
Mentorship Program
Dr. Sherman uses a multi-disciplinary team approach which is focused on the treatment of neuro-oncology patients with both surgical and non-surgical treatment protocols. He is a clinician-scientist working from the bench to the bedside where he performs translational research in an effort to provide a direct impact by advancing treatments for his patients.
Dr. Sherman excels in the use of stereotactic radiosurgery to treat cranial and spinal tumors, including meningioma, acoustic neuroma, pituitary tumors, and brain and spine metastases.
He is also a pioneer in the use of patient-specific Virtual Reality for surgical planning and patient education.
Research Interests
Neural stem cells in the origin and treatment of brain tumors
Cold atmospheric plasma in the treatment of brain tumors
Radiosensitizing agents in post-operative adjuvant management of brain tumors
Virtual Reality for Patient Engagement and Surgical Planning
